Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2026-01-18 @ 6:35 PM
Study NCT ID:
NCT03218995
Status:
COMPLETED
Last Update Posted:
2021-12-09
First Post:
2017-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
Sponsor:
Sarepta Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-09
First Submit QC Date:
None
Study First Post Date:
2017-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-10
Results First Submit QC Date:
None
Results First Post Date:
2021-12-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-10
Last Update Post Date:
2021-12-09
Last Update Post Date Type:
ACTUAL